LADENBURG THALMANN FINANCIAL SERVICES INC. - DELMAR PHARMACEUTICALS INC ownership

DELMAR PHARMACEUTICALS INC's ticker is DMPI and the CUSIP is 247078207. A total of 13 filers reported holding DELMAR PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of DELMAR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$20,000
+42.9%
40,0000.0%0.00%
Q4 2018$14,000
-51.7%
40,0000.0%0.00%
Q3 2018$29,000
-27.5%
40,000
-5.6%
0.00%
Q2 2018$40,0000.0%42,3750.0%0.00%
Q1 2018$40,00042,3750.00%
Other shareholders
DELMAR PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Crescent Grove Advisors, LLC 50,000$47,0000.01%
Virtu Financial LLC 37,685$35,0000.00%
TRUSTCORE FINANCIAL SERVICES, LLC 5,000$5,0000.00%
FRANKLIN RESOURCES INC 1,076,923$1,012,0000.00%
CREDIT SUISSE AG/ 13,571$13,0000.00%
BANK OF MONTREAL /CAN/ 4,262$4,0000.00%
Citadel Advisors 15,335$14,0000.00%
TWO SIGMA SECURITIES, LLC 23,391$22,0000.00%
Raymond James Financial Services Advisors, Inc. 12,500$12,0000.00%
ROYAL BANK OF CANADA 500$00.00%
View complete list of DELMAR PHARMACEUTICALS INC shareholders